Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FS Investments is a leading alternative asset manager specializing in private equity, private credit, and real estate. The firm manages over $82 billion in assets for institutional and wealth management clients globally, following its 2023 acquisition of Portfolio Advisors. It offers a broad suite of differentiated strategies across private markets but does not operate in the life sciences, biotech, pharma, or healthcare product development sectors. While "FS Investments" manages significant capital including healthcare-related investments via private equity or credit strategies targeting healthcare companies as part of diversified portfolios/funds they do not themselves operate as a biotech/pharma/life science R&D entity nor do they have pipelines/modalities/targets typical for such firms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FS Investments.